We're thrilled to have experienced such a great turnout and interest at the ECR in Vienna last week! Once again, it's been confirmed that we're on the right track. Our major advantage is that we offer "Prostate.Carcinoma.ai" to our customers as fully integratable software.

Our AI-based software Prostate.Carcinoma.ai supports radiologists in the detection and segmentation of the prostate gland, their zones and suspicious lesions on MRI images. Mint Medical was involved in our software development from the very beginning with advice and their experiences as platform developer for radiologists.